Anti-parasite drug ivermectin can suppress ovarian cancer by regulating lncRNA-EIF4A3-mRNA axes
ConclusionThose findings provided the potential targeted lncRNA-EIF4A3-mRNA pathways of ivermectin in OC, and constructed the effective prognostic model, which benefits discovery of novel mechanism of ivermectin to suppress ovarian cancer cells, and the ivermectin-related molecule-panel changes benefit for its personalized drug therapy and prognostic assessment towards its predictive, preventive, and personalized medicine (PPPM) in OCs.
Source: EPMA Journal - Category: International Medicine & Public Health Source Type: research
More News: Cancer | Cancer & Oncology | Databases & Libraries | International Medicine & Public Health | Ovarian Cancer | Ovaries | Parasitic Diseases | Parasitology | Study